SUMMARY This clinical and experimental investigation was designed to delineate and compare the relative effects of sodium nitroprusside (NP) and nitroglycerin (TNG) on electrocardiographic ischemic injury following acute myocardial infarction in patients and following coronary artery occlusion in dogs. Accordingy, in ten patients with anterior acute myocardial infarction and ST-segment elevation stable for 60 min, the effects of NP (average 95 4g/min i.v.) and TNG (average 0.48 mg sublingually) were studied. The hemodynamic actions of NP and TNG were directionally similar. However, NP increased average ST-segment elevation (ST) by 2.0 ± 0.2 mm, while TNG reduced ST by 1.4 ± 0.4 mm. In order to clarify this disparity, coronary artery occlusions were carried out in 14 open-chest dogs. During control, NP and TNG time periods, epicardial electrograms were recorded and regional myocardial blood CARDIAC FAILURE, as manifested by shock and/or pulmonary edema, is the major life-threatening complication of acute myocardial infarction in hospitalized patients. This is most likely the consequence of an extensive infarction,l' 2 hence reduction in the extent of myocardial necrosis may constitute a major therapeutic goal. Since the extent of myocardial necrosis depends on the energy balance in the ischemic zone,3 the reduction of preload and afterload, which may reduce myocardial oxygen requirements, has been proposed as a means of minimizing the area of necrosis. The drugs most widely used to decrease preload and afterload are nitroglycerin'4 and sodium nitroprusside,10 13 which improve the cardiac performance in patients with acute myocardial infarction. Although it is known that nitroglycerin may lessen myocardial injury,'6 8' 9 no information is available comparing the action of these two drugs on the severity and the extent of myocardial damage. Accordingly, this study was designed to evaluate the effects of nitroglycerin (TNG) and nitroprusside (NP) both on the mechanical performance of the heart and on the electrocardiographic ischemic injury in patients with acute myocardial infarction. The study further sought explanations for their contrasting actions on myocardial damage through a comparison of their effects on coronary collateral flow in dogs. flow (RMBF) determined by the microsphe te N side increased ST-egment elevation from 4.6 ± 0.6 to 5.7 ± 0.6 mV (P < 0.05) and reduced RMBF from 35 ± 3 to 27 ± 2 mI/uul/100 g (P < 0.01) in the ischemic zones. In contrs, TNG reced; STsegment elevation from 4.9 ± 0.7 to 3.0 ± 0.7 mV (P < 0.05), Wle increasing RMBF to 43 ± 4 ml/mi/100 g (P < 0.05) and the endo/epicardial ratio from 0.57 ± 0.06 to 0.69 ± 0.07 (P < 0.01). Although TNG and NP exhibit similar hemodynamic effects, TNG reduced electrocardiographic ischemic injury, at least in part, by increasing perfusion of the ischemic areas and redistriutng it favorably, while NP increased electrocardiographic iscbemic injury, at least in part, by reducing perfusion. Therefore, TNG seems preferable to NP for reducing preload and afterload in ts during the early phase of acute myocardial infarction.
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Materials and Methods

Observations in Patients
Ten patients with acute transmural anterior myocardial infarction, documented by history, electrocardiographic patterns, and enzymatic changes, were studied within the first eight hours from the onset of pain. Only patients with stable ST-segment elevation in the six precordial leads (V,-V.) for at least one hour before the beginning of the study were included in this series. Pulmonary artery pressure and pulmonary capillary wedge pressure (PCW) were monitored by a Swan-Ganz flow-directed, balloon-tipped catheter. Systemic arterial pressure (AP) was monitored through a cannula in the radial artery. Precordial electrocardiograms were obtained in positions from V1 through V6 and in the corresponding positions one intercostal space above and one intercostal space below. The lead with maximal ST-segment elevation was thereafter continuously recorded and STsegment elevation measured.
After the initial control period, during which the stability of the ST-segment elevation was assessed, NP was infused intravenously at a mean rate of 95 ,gg/min (25 to 150). This dose was gradually titrated to obtain the desired hemodynamic effects and then was maintained constant for 10 min. In five of these ten patients 15 Cardiac output and RMBF were measured 15, 30, and 45 min after coronary artery occlusion using carbonized microspheres, size 7-10,u (3M Company), labeled with gammaemitting radionuclides "'Ce, 'Sc, and "Sr, according to techniques previously described.'5 16 The microspheres, suspended in a solution of sucrose, 50%, with two drops of Tween 80 in order to avoid aggregation, were subjected to ultrasound for 45 min before use. Fifteen, 30, and 45 min after the occlusion, 4 ml containing 1.5 X I0V of one type of labeled microsphere were injected over 15 sec through a catheter placed in the left atrium; during the next 15 sec the catheter was flushed with 5 ml saline. Simultaneously, a reference sample was collected through a catheter placed in the femoral artery using a 50 ml heparinized plastic syringe placed in a Harvard withdrawal pump operating at a constant rate of 15.3 ml/min. No changes in heart rate or arterial pressure were observed after the injection.
At the end of the experiment, 45 min after the occlusion, the heart was rapidly excised and seven or eight transmural biopsies (weighing 2.59 ± 0.06 g) were obtained. They contained all the ischemic tissue as well as normal portions from the anterior and posterior ventricular walls. The biopsies were then divided into endocardial and epicardial layers. The radioactivity of the reference blood sample and of the tissue specimens was counted in a Nuclear Chicago well counter (model 4233). Calculations of RMBF and cardiac output (CO) were made as described by Utley et al. '7 Endocardial, epicardial, and transmural RMBF of the normal and of the ischemic sites were compared separately, considering each site where the flow was less than 50 ml/min/100 g to be ischemic. The comparison of the flows was made between the values obtained after the control period of 15 min and those collected after 30 and 45 min, using the Student's paired t-test.
Results
Effects of Sodium Nitroprusside and Nitroglycerin in Patients
The administration of NP in the ten patients studied reduced the AP by 26 ± fig. 1 ).
In the five patients who received both drugs, the administration of NP and TNG resulted in hemodynamic effects of similar direction ( fig. 2) . Nitroprusside reduced AT by 24 ± 5 mm Hg (from 105 + 10 to 81 + 8 mm Hg, P < 0.01) and pulmonary capillary wedge pressure by 5 ± I mm Hg (from 19 ± 2 to 14 + 3 mm Hg, P < 0.02). Following the administration of TNG, AT fell similarly, by 14 ± 4 mm Hg (from 112 ± 9 to 98 ± 10 mm Hg, P < 0.05) and the PCWby9 ± 3 mm Hg (from 21 ± 4to 12 ± 4mm Hg, P < 0.01). Nitroprusside increased heart rate by 12 + 5 beats/min (from 88 ± 7 to 100 ± 9 [P < 0.051) while with TNG it did not change significantly (from 82 + 10 to 83 ± 10 [NS]).
In contrast to their directional effects on arterial and wedge pressures, these drugs had different effects on STsegment elevations. Average ST-segment elevation rose by 2.4 ± 0.3 mm (P < 0.01) following NP administration. This elevation was transient and ST-segments returned to their pre-NP levels except in patient 8, in whom the elevation continued until treatment with TNG ( figs. 2 and 3 (fig. 6, left panel) . In the ischemic sites transmural flow 15 min after the occlusion was 35.4 ± 2.7 ml/min/100 g; following 15 min of NP infusion flow had decreased to 27.4 ± 2.9 ml/min/100 g (P < 0.01) ( fig. 6, right panel) . After (86.4 ± 5.7 ml/min/100 g, fig. 6 , left panel). In the ischemic sites it rose to 42.9 ± 3.7 ml/min/100 g, which is higher than in both the NP (P < 0.01) and the control (P < 0.05) periods ( fig. 6, right panel) . Changes in the endo-and epicardial blood flows paralleled those of the transmural sections (table 3) . Therefore, in the nonischemic sites NP reduced flow and TNG had no effect; in the ischemic sites NP continued to reduce RMBF while TNG increased it. In the seven control dogs, there were only small changes in the RMBF at 30 and 45 min: thus, the transmural flow in the nonischemic zone changed from 94.4 ± 3.7 to 92.4 ± 4.3 ml/min/100 g between 15 and 45 min, and in the ischemic area, from 24.5 ± 2.6 to 21.9 ± 2.6 ml/min/100 g.
The endo/epicardial flow ratio in the nonischemic sites did not change significantly (table 3) . The endo/epicardial flow ratio in the ischemic zone was 0.57 ± 0.06 after the initial 15 control min. It did not change significantly after NP infusion and was 0.52 ± 0.07 (NS) at 30 min. However, after TNG it increased significantly to 0.69 ± 0.07 (P < 0.01 when compared either to the control or NP periods) ( fig. 7, table 3 effect on flow redistribution. In the nontreated group the endo/epicardial ratio did not change significantly either in the nonischemic or in the ischemic zones.
Discussion
In recent years nitroprusside and nitroglycerin have been used to reduce preload and afterload during the treatment of cardiac failure following myocardial infarction. Their beneficial hemodynamic effects are clearly defined.' 18 18, 19 Moreover, by decreasing the cardiac work and the oxygen consumption, it is possible that these drugs can decrease the extent of necrotic tissue;" in an experimental model, Kjekshus has shown that reduction in preload decreases ischemic myocardial damage.'0 However, since these drugs may have important additional pharmacologic effects, the present investigation was designed primarily to compare their actions in patients with acute myocardial infarction, paying special attention to their effects on ischemic injury. For this purpose we evaluated ST-segment elevations since it has been demonstrated that epicardial ST-segment elevations following acute coronary artery occlusion correlate with the amount of necrosis as reflected in histologic appearance and creatine phosphokinase depletion of myocardial biopsies obtained 24 hours after occlusion." 1 The system that was used in this study (i.e., single lead) is probably less sensitive than the multiple lead electrocardiogram in assessing the amplitude of electrocardiographic changes, and this latter technique should be preferred when evaluating drug-induced alterations. However, the single lead allowed us to observe directional changes and had the advantage of allowing continuous monitoring, which is important with fast-acting and potentially harmful drugs.
Despite similar hemodynamic effects, contrasting results were observed with the two drugs: TNG reduced electrocardiographic myocardial injury while NP increased it. It should be pointed out that in this study TNG was always administered after NP because of the long action of the latter. However, since NP increases the electrocardiographic injury, despite its favorable effects on the hemodynamic parameters, this sequence of administration of the two drugs did not introduce bias in favor of TNG. Moreover, our find- The increase in heart rate that occurred after NP administration could be a factor in augmenting ST-segment elevation.3' 24 However, since this increase in heart rate was rather moderate (average 10 beats/min) and since patients 2, 4, 7, and 10 (table 1) had changes of heart rate of only +2, -6, +5 and +5 beats/min, respectively, and yet increased their ST-segment elevations, it seems that the increase in heart rate was not an important factor.
The experimental part of the study is in accord with this interpretation since there was no disparity between NP and TNG with regard to heart rate and arterial pressure, while ST-segments changed in opposite directions. The opposite effects of the two drugs in patients stimulated us to evaluate the comparative effects of these two drugs on electrocardiographic ischemic injury in an animal model, in which the experimental conditions could be better standardized and myocardial blood flow could be studied simultaneously in an effort to explain the mechanism for the alterations in the extent of electrocardiographic myocardial damage.
The observations in open-chest dogs with coronary occlusion confirmed the electrocardiographic findings in patients and demonstrated that the magnitude of ischemic injury was increased by nitroprusside and reduced by nitroglycerin (figs. 2, 3, and 5). The measurements of regional myocardial blood flow explained, at least in part, the paradoxical action of the two drugs. Nitroprusside decreased myocardial flow to the ischemic tissue while TNG both augmented and redistributed it more favorably, increasing the endo/epicardial flow ratio. The alterations in ST-segment elevations seem to be the result of changes in regional flow in the ischemic area since their simultaneous measurements showed that reductions in flow, as a consequence of NP administration, were accompanied by increases in ST-segment elevation, while an augmentation of flow, brought about by TNG, was accompanied by a reduction in ST-segment elevation ( fig. 8 ).
The differences between the action of the two drugs on regional myocardial blood flow cannot be explained by their hemodynamic effects since both drugs had similar actions. Therefore the different effects on the coronary bed of the drugs must account for the disparate effects on RMBF and electrocardiographic ischemic injury. It has been suggested21528 that TNG acts in the coronary circulation primarily by dilating large conductance vessels while its action on the small resistance vessels is of a small magnitude and transitory. This effect on the conductance vessels may account for the increase and the redistribution of flow in the ischemic areas, in spite of the fall in perfusion pressure. In contrast, NP may decrease the collateral flow to the area of ischemia due to a reduction in perfusion pressure or due to its dilating action on the resistance vessels,2" 30 resulting in a "coronary steal." The blood from the underperfused zone, already under maximal metabolic dilating stimulus,81 may be shunted to the adjacent nonischemic myocardium, where the vascular resistance can still be reduced by the drug, analogous to the original description of the coronary steal mechanism as applied to restriction of flow by stenosis.
This study indicates that both NP and TNG can produce important hemodynamic improvements in patients with acute myocardial infarction through a reduction of preload 
